Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun;116(3):163-169.
doi: 10.32074/1591-951X-955.

SMARCB1/INI1-deficient undifferentiated tumour of the thorax: a case report and review of the literature

Affiliations
Review

SMARCB1/INI1-deficient undifferentiated tumour of the thorax: a case report and review of the literature

Moreno Zagni et al. Pathologica. 2024 Jun.

Abstract

The 5th WHO classification of thoracic tumours includes thoracic SMARCA4-deficient undifferentiated tumour (SMARCA4-UT) among the "other epithelial tumours of the lung" chapter. Herein, we present a case of undifferentiated thoracic neoplasm with retention of SMARCA4 expression, lack of NUT fusion protein and loss of SMARCB1/INI1 expression. After presenting the clinical and pathological features of the tumour, we carried out a review of the literature on the same topic. Albeit very rare, we believe this entity should be included in the heterogeneous group of undifferentiated neoplasms of the thorax.

Keywords: SMARCA4-deficient undifferentiated tumour; SMARCB1-deficient undifferentiated tumour; SWI/SNF complex; thoracic undifferentiated tumours.

PubMed Disclaimer

Conflict of interest statement

C.L. reports honoraria from Roche. All other authors declare no conflict of interest.

Figures

Figure 1.
Figure 1.
CT image of the reported case. Thoracic computed tomography at initial diagnosis. The image shows a grossly rounded, solid formation located peripherically in the right middle lobe of the lung.
Figure 2.
Figure 2.
Histopathological and immunohistochemical features of the tumour. Haematoxylin and eosin staining of the lesion showed a solid proliferation of small, round, undifferentiated cells with focal necrosis, occasional cytoplasmic vacuolisation and perivascular palisading (a). Neoplastic cells stained positive for p40 (50% of the neoplastic cells) and negative for TTF-1 and synaptophysin (b, c, d). Immunohistochemical study of the expression of SMARCA4/BRG1 (e) and SMARCB1/INI1 (f) demonstrated the retention of the former and the complete loss of staining, with positive internal control, of the latter.

References

    1. Kohashi K, Oda Y. Oncogenic roles of SMARCB1/INI1 and its deficient tumors. Cancer Sci. 2017;108(4):547-552. https://doi.org/10.1111/cas.13173 10.1111/cas.13173. Epub 2017 Apr 12. PMID: ; PMCID: . - DOI - PMC - PubMed
    1. Board WC. Thoracic Tumours: WHO Classification of Tumours. World Health organ classif tumours. 5th ed. Lyon France: International Agency for Research on Cancer; 2021.
    1. Nicholson AG, Tsao MS, Beasley MB, et al. . The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015. J Thorac Oncol. 2022;17(3):362-387. https://doi.org/10.1016/j.jtho.2021.11.003 10.1016/j.jtho.2021.11.003. Epub 2021 Nov 20. PMID: . - DOI - PubMed
    1. Nambirajan A, Jain D. Recent updates in thoracic SMARCA4-deficient undifferentiated tumor. Semin Diagn Pathol. 2021;38(5):83-89. https://doi.org/10.1053/j.semdp.2021.06.001 10.1053/j.semdp.2021.06.001. Epub 2021 Jun 4. PMID: . - DOI - PubMed
    1. Parker NA, Al-Obaidi A, Deutsch JM. SMARCB1/INI1-deficient tumors of adulthood. F1000Res. 2020;30(9):662. https://doi.org/10.12688/f1000research.24808.2 10.12688/f1000research.24808.2. PMID: ; PMCID: . - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources